Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
2,666,344
-
Shares change
-
-258,866
-
Total reported value, excl. options
-
$114,994,244
-
Value change
-
-$11,070,727
-
Put/Call ratio
-
144%
-
Number of buys
-
31
-
Number of sells
-
26
-
Price
-
$43.13
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q1 2024
As of 31 Mar 2024 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,666,344 shares of stock of the company.
Largest 10 holders included Clal Insurance Enterprises Holdings Ltd, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, LPL Financial LLC, GOLDMAN SACHS GROUP INC, Kingsview Wealth Management, LLC, WELLS FARGO & COMPANY/MN, FIRST CITIZENS BANK & TRUST CO, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and BNP PARIBAS FINANCIAL MARKETS.
This table shows 85 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.